COMPAGNUCCI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 5.189
AS - Asia 2.432
EU - Europa 1.734
SA - Sud America 470
Continente sconosciuto - Info sul continente non disponibili 226
AF - Africa 178
OC - Oceania 7
Totale 10.236
Nazione #
US - Stati Uniti d'America 4.952
SG - Singapore 680
IT - Italia 631
VN - Vietnam 579
HK - Hong Kong 402
CN - Cina 394
BR - Brasile 354
RU - Federazione Russa 324
CA - Canada 137
DE - Germania 132
FR - Francia 116
IE - Irlanda 113
GB - Regno Unito 101
BD - Bangladesh 96
SE - Svezia 85
MA - Marocco 65
IN - India 59
CI - Costa d'Avorio 53
FI - Finlandia 53
MX - Messico 46
AR - Argentina 37
NL - Olanda 32
ZA - Sudafrica 32
PL - Polonia 27
ID - Indonesia 24
JP - Giappone 24
TR - Turchia 24
ES - Italia 23
IQ - Iraq 21
AT - Austria 20
CO - Colombia 17
UA - Ucraina 16
CL - Cile 14
PH - Filippine 14
UZ - Uzbekistan 13
LT - Lituania 12
PK - Pakistan 12
SA - Arabia Saudita 12
VE - Venezuela 12
EC - Ecuador 11
DZ - Algeria 10
AE - Emirati Arabi Uniti 8
RO - Romania 8
AL - Albania 7
BO - Bolivia 7
HN - Honduras 7
JO - Giordania 7
KR - Corea 7
PY - Paraguay 7
BE - Belgio 6
CH - Svizzera 6
GE - Georgia 6
IL - Israele 6
NI - Nicaragua 6
PE - Perù 6
CR - Costa Rica 5
JM - Giamaica 5
MY - Malesia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
TH - Thailandia 5
TW - Taiwan 5
UY - Uruguay 5
DM - Dominica 4
GT - Guatemala 4
KZ - Kazakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
KW - Kuwait 3
AU - Australia 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
EG - Egitto 2
HR - Croazia 2
IR - Iran 2
KE - Kenya 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GD - Grenada 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 9.997
Città #
Ashburn 1.238
Singapore 437
Hong Kong 387
San Jose 318
Council Bluffs 292
Chandler 259
Dallas 249
Ho Chi Minh City 181
Hanoi 151
Los Angeles 136
New York 119
Beijing 110
Dublin 106
Boardman 105
Phoenix 88
The Dalles 81
Lauterbourg 68
Ancona 61
Milan 59
Santa Clara 58
Moscow 57
Munich 56
Abidjan 53
Chicago 49
São Paulo 48
Hefei 47
Orem 46
Turin 46
Des Moines 45
Montreal 45
Rome 45
Fairfield 44
Helsinki 36
San Francisco 36
Seattle 36
Brooklyn 32
Atlanta 30
Toronto 30
Denver 29
Frankfurt am Main 27
Wilmington 26
Da Nang 24
Haiphong 24
London 24
Boston 23
Buffalo 23
Nuremberg 23
Warsaw 23
Lawrence 22
Mexico City 22
Tokyo 22
Houston 21
Princeton 21
Chennai 18
Jacksonville 18
Cambridge 17
Manchester 17
Shanghai 17
Stockholm 17
Turku 17
Woodbridge 17
Washington 15
Amsterdam 14
Destin 14
Johannesburg 14
Rio de Janeiro 14
Tolentino 14
Lynnwood 13
Vienna 13
Columbus 12
Kazan' 11
Poplar 11
Ankara 10
Bắc Ninh 10
Miami 10
Paris 10
Pune 10
Salt Lake City 10
Tampa 10
Ann Arbor 9
Biên Hòa 9
Hải Dương 9
Palermo 9
Porto Alegre 9
Tashkent 9
Belo Horizonte 8
Cagliari 8
Calgary 8
Miano 8
Naples 8
Nha Trang 8
Santiago 8
Shenzhen 8
Thái Nguyên 8
Belton 7
Can Tho 7
Cape Town 7
Curitiba 7
Dhaka 7
Jeddah 7
Totale 6.159
Nome #
Interpretation and management of premature ventricular beats in athletes: An expert opinion document of the Italian Society of Sports Cardiology (SICSPORT) 601
National workflow experience with pulsed field ablation for atrial fibrillation: learning curve, efficiency, and safety 282
Recent advances in three-dimensional electroanatomical mapping guidance for the ablation of complex atrial and ventricular arrhythmias 205
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 192
Cardiac imaging in athlete’s heart: The role of the radiologist 183
Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: Real-world insights from the iSUSI registry 182
Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation: Results of a multicenter, real-world experience 177
Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study 163
Arrhythmic Mitral Valve Prolapse and Sports Activity: Pathophysiology, Risk Stratification, and Sports Eligibility Assessment 161
Worldwide Survey of COVID-19-Associated Arrhythmias 159
Pathophysiology of Typical Atrial Flutter 158
Different Phases of Disease in a Highly Characterized Cohort of Lymphocytic Myocarditis: Clinical and Electrophysiological Characteristics 157
Recurrence of atrial fibrillation post-ablation: which is the most effective approach for detection? 149
Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachycardia: A Comparison With Fluoroscopy-Guided Approach 148
Myocardial Infarction Without Obstructive Coronary Artery Disease (MINOCA): A Practical Guide for Clinicians 147
Posterior wall ablation for persistent atrial fibrillation: Very-high-power short-duration versus standard-power radiofrequency ablation 144
Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience 142
Implantable defibrillator-detected heart failure status predicts ventricular tachyarrhythmias 142
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases 141
Acute Kidney Injury Resulting From Hemoglobinuria After Pulsed-Field Ablation in Atrial Fibrillation: Is it Preventable? 140
High-power short-duration catheter ablation of atrial fibrillation: is it really a new era? Comparison between new and old radiofrequency contact force–sensing catheters 139
Myocardial inflammation, sports practice, and sudden cardiac death: 2021 update 138
Characteristics and Clinical Value of Electroanatomic Voltage Mapping in Cardiac Amyloidosis 132
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 131
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 131
Safety and Efficacy of Stereotactic Arrhythmia Radioablation for the Treatment of Ventricular Tachycardia: A Systematic Review 131
Atrial Flutters in Adults with Congenital Heart Disease 130
Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience 130
Microelectrode voltage mapping for substrate assessment in catheter ablation of ventricular tachycardia: A dual-center experience 128
Derivation and Validation of a Clinical Score for Predicting Postoperative Atrial Fibrillation in Noncardiac Elective Surgery (the HART Score) 128
Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm 127
Efficacy of Catheter Ablation for Atrial Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy-A Multicenter Study 123
Atrial Flutter in Particular Patient Populations 122
Idiopathic Premature Ventricular Contraction Catheter Ablation, Sedentary Population vs. Athlete’s Populations: Outcomes and Resumption of Sports Activity 121
Different Phases of Disease in Lymphocytic Myocarditis: Clinical and Electrophysiological Characteristics 121
Cardiac Magnetic Resonance and Cardiac Implantable Electronic Devices: Are They Truly Still "Enemies"? 120
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 119
Endomyocardial biopsy: The forgotten piece in the arrhythmogenic cardiomyopathy puzzle 119
Myocardial Ischemia/Reperfusion Injury: Molecular Insights, Forensic Perspectives, and Therapeutic Horizons 117
Angina in 2022: Current Perspectives 116
Forensic perspectives on postmortem CIED interrogation: A systematic review and meta-analysis 113
P-Waves Are the Main Clues for Correct ECG Interpretation 111
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 107
Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation 106
Intraprocedural PRAETORIAN score for early assessment of S-ICD implantation: A proof-of-concept study 105
Technological advances in ventricular tachycardia catheter ablation: the relentless quest for novel solutions to old problems 104
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers 104
Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study 104
Incidence of ventricular arrhythmias related to COVID infection and vaccination in patients with Brugada syndrome: Insights from a large Italian multicenter registry based on continuous rhythm monitoring 103
Pulsed-field ablation of atrial fibrillation: kinetics of release of multiple cardiac biomarkers 103
Etiology and device therapy in complete atrioventricular block in pediatric and young adult population: Contemporary review and new perspectives 103
Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis 102
Catheter Ablation for Ventricular Tachycardia in Patients With Desmoplakin Cardiomyopathy 102
Endomyocardial biopsy in the hands of the electrophysiologist: the ‘one-stop shop’ for arrhythmic non-ischaemic cardiomyopathy. Letter regarding the article ‘Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy’ 101
Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry 100
Direct Epicardial Validation of Posterior Wall Electroporation in Persistent Atrial Fibrillation 99
Implantable loop recorders in patients with Brugada syndrome: the BruLoop study 99
Intracardiac echocardiography-guided pulsed-field ablation for successful ablation of atrial fibrillation: a propensity-matched analysis from a large nationwide multicenter experience 99
Advancing diagnosis in a cardiac arrest case and suspected MINOCA: the complementary roles of imaging, biopsy, and genetic testing 98
The Role of Cardiac Resynchronization Therapy for the Management of Functional Mitral Regurgitation 96
Electroanatomic Mapping System and Intracardiac-Echo to Guide Endomyocardial Biopsy 95
Impact of ventricular tachycardia ablation in subcutaneous implantable cardioverter defibrillator carriers: a multicentre, international analysis from the iSUSI project 94
Ventricular fibrillation recurrences in successfully shocked out-of-hospital cardiac arrests 94
Stepwise endo-/epicardial catheter ablation for atrial fibrillation: The Mediterranea approach 94
Pulsed field ablation technology for pulmonary vein and left atrial posterior wall isolation in patients with persistent atrial fibrillation 90
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy 88
Atrial tachyarrhythmia recurrence after cryobaloon ablation: does thickness imply failure? 87
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe 83
Ventricular arrhythmias in athletes: Role of a comprehensive diagnostic workup 81
Atrial fibrillation cycle-length (AF-CL) inside the pulmonary veins predicts paroxysmal AF ablation success— the INDUCE-AF study 81
Oral Anticoagulation and Factor VIII Replacement Therapy in Patients With Hemophilia Undergoing Pulsed-Field or Radiofrequency Catheter Ablation for Atrial Fibrillation 79
Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy 77
Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure: a prediction model 75
One-year outcomes of the Mediterranea technique for longstanding persistent atrial fibrillation 73
The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator 71
Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy 71
γ-H2AX: A useful tool to detect DNA damage in sudden cardiac death heart tissues, an experimental study 64
The History of Atrial Flutter Electrophysiology, from Entrainment to Ablation: A 100-Year Experience in the Precision Electrocardiology 54
Cardiac biomarker temporal dynamics after radiofrequency and pulsed field catheter ablation of atrial fibrillation 50
Does Age Impact Safety and Efficacy During Pulse-Field Ablation for Atrial Fibrillation? 50
Differentiating sensor changes in a composite heart failure ICD monitoring index: clinical correlates and implications 46
Fascicular tachycardia ablation using optrell mapping catheter: a case report 39
Mitochondria at the Crossroads of Cardiovascular Disease: Mechanistic Drivers and Emerging Therapeutic Strategies 35
Brugada Syndrome in Sports Cardiology: An Expert Opinion Statement of the Italian Society of Sports Cardiology (SICSport) 34
Determinants of Left Atrial Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation and Atrial Flutter 31
Catheter Ablation of Atrial Fibrillation in Patients With Psoriasis: A Multicenter Study 30
Long-Term Risk Assessment in Athletes With Complex Ventricular Arrhythmias 24
Temporal trends of characteristics and management of patients with suspected MINOCA 23
AI-Assisted 3D Intracardiac Echocardiography for Pulsed Field Ablation of Atrial Fibrillation Using a Novel Variable Loop Circular Catheter: A Multicenter Evaluation 21
How can we improve on selecting the appropriate therapy in Brugada syndrome? 20
De Novo Pulmonary Vein Isolation by Means of Pulsed Field Versus Conventional Thermal Ablation of Paroxysmal Atrial Fibrillation in Women: Safety, Efficiency, and Efficacy 15
The Clinical Significance of Atrial Fibrillation in Non–High-Risk Brugada Syndrome 12
Totale 10.236
Categoria #
all - tutte 42.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022171 0 0 0 0 57 4 4 10 25 18 16 37
2022/2023743 29 67 38 101 39 115 0 56 158 12 81 47
2023/2024468 66 19 37 47 72 73 5 30 36 28 13 42
2024/20251.445 109 129 54 23 65 37 126 59 233 182 142 286
2025/20265.334 442 325 247 578 470 293 1.024 397 422 503 329 304
2026/20271.921 408 510 376 627 0 0 0 0 0 0 0 0
Totale 10.236